KR950703938A - 하부소화관 방출성의 경구의약제제(oral pharmaceutlcal preparation releasable in the lower digestive tract) - Google Patents

하부소화관 방출성의 경구의약제제(oral pharmaceutlcal preparation releasable in the lower digestive tract) Download PDF

Info

Publication number
KR950703938A
KR950703938A KR1019950701773A KR19950701773A KR950703938A KR 950703938 A KR950703938 A KR 950703938A KR 1019950701773 A KR1019950701773 A KR 1019950701773A KR 19950701773 A KR19950701773 A KR 19950701773A KR 950703938 A KR950703938 A KR 950703938A
Authority
KR
South Korea
Prior art keywords
digestive tract
acid
oral pharmaceutical
lower digestive
pharmaceutical preparation
Prior art date
Application number
KR1019950701773A
Other languages
English (en)
Other versions
KR0157280B1 (ko
Inventor
미네노부 오카야마
마사루 나카니시
Original Assignee
나까토미 히로타카
히사미쯔세이야꾸 가부시기가이샤(Hisamitsu Pharmaceutical Co., Inc)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나까토미 히로타카, 히사미쯔세이야꾸 가부시기가이샤(Hisamitsu Pharmaceutical Co., Inc) filed Critical 나까토미 히로타카
Publication of KR950703938A publication Critical patent/KR950703938A/ko
Application granted granted Critical
Publication of KR0157280B1 publication Critical patent/KR0157280B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 활성성분을 함유하는 핵으로 이루어진 고형약제를 양이온성폴리머로 이루어진 내부층, 음이온성 폴리머로 이루어진 외부층을 각각 피복해서 이루어진 2중피복구조를 가진 것을 특징으로 하는 하부소화관방출성의 경구의약제제.

Description

하부소화관 방출성의 경구의약제제(ORAL PHARMACEUTLCAL PREPARATION RELEASABLE IN THE LOWER DIGESTIVE TRACT)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 인비트로에 의한 약물의 방출성 시험을 표시한 그래프,
제2도는 인비보에 의한 약물의 혈중농도시험을 표시한 그래프,
제3도는 인비트로에 의한 코팅중량변화에 대한 방출성시험을 표시한 그래프,
제4도는 pH변화에 대한 케트프로펜의 방출성 시험을 표시한 그래프,
제5도는 pH변화에 대한 FITC덱스트란의 방출성시험을 표시한 그래프.

Claims (7)

  1. 활성성분을 하유하는 핵으로 이루어진 고형약제를, 양이온성폴리머로 이루어진 내부층, 음이온성 폴리머로 이루어진 외부층을 각각 피복해서 이루어진 2중피복구조를 가진 것을 특징으로 하는 하부소화관방출성의 경구의약제제.
  2. 제1항에 있어서, 상기 핵이 흡수촉진제를 함유하는 것을 특징으로 하는 하부소화관 방출성의 경구의약제제.
  3. 제2항에 있어서, 상기 흡수촉진제가 슈거에스테르, 자당지방산에스테르, 글리실리진산염, 글리틸레틴산, 글리틸리틴산디칼륨, 담즙산, 글리세린지방산에스테르, 1-〔2-(데실티오)에틸〕아자시클로 펜탄2-온, 아디핀산, 염기성아미노산, 폴리에틸렌글리콜, 카프린산나트륨로부터 선택되는 것을 특징으로 하는 하부소화관방출성의 경구의약제제.
  4. 제1항에 있어서, 상기 양이온성폴리머가, pH6.0이하에서 가용성 또는 팽윤성을 표시하는 아미노알킬메타아크릴레이트코폴리머 또는 폴리비닐아세탈디에틸아미노아세테이트인 것을 특징으로 하는 하부소화관방출성의 경구의약제제.
  5. 제1항에 있어서, 상기 음이온성폴리머가, pH5.5이하에서 용해하는 메타아크릴산코폴리머L, 메타아크릴산코폴리머S, 히드록시프로필메틸셀룰로스, 히드록시에틸셀룰로스프달레이트, 폴리비닐아세테이트프탈레에트, 셀룰로스아세테이트 및 셀룰로스아세테이트테트라히드로프탈레이트로 이루어진 군으로부터 선택되는 것을 특징으로 하는 하부소화관방출성의 경구의약제제.
  6. 제1항에 있어서, 상기 소화관내의 pH7.0∼5.5범위이하로 변화하는 하부소화관내에 있어서 붕괴흡수하는 것을 특징으로 하는 하부소화관방출성의 경구의약제제.
  7. 제1항에 있어서, 상기 활성성분이 펩타이드, 담백질, 항염증제, 항종양제, 항생물질 및 화학료법제로 이루어진 군으로부터 선택되는 것을 특징으로 하는 하부소화관방출성의 경구의약제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950701773A 1992-11-06 1993-11-05 하부소화관 방출성의 경구의약제제 KR0157280B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP92-322478 1992-11-06
JP32247892 1992-11-06
PCT/JP1993/001608 WO1994010983A1 (en) 1992-11-06 1993-11-05 Peroral pharmaceutical preparation releasable in lower digestive tract

Publications (2)

Publication Number Publication Date
KR950703938A true KR950703938A (ko) 1995-11-17
KR0157280B1 KR0157280B1 (ko) 1998-11-16

Family

ID=18144084

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701773A KR0157280B1 (ko) 1992-11-06 1993-11-05 하부소화관 방출성의 경구의약제제

Country Status (9)

Country Link
US (1) US5654004A (ko)
EP (1) EP0667148B1 (ko)
KR (1) KR0157280B1 (ko)
AU (1) AU5376894A (ko)
CA (1) CA2148465C (ko)
DE (1) DE69332082T2 (ko)
DK (1) DK0667148T3 (ko)
ES (1) ES2176209T3 (ko)
WO (1) WO1994010983A1 (ko)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US6117453A (en) * 1995-04-14 2000-09-12 Pharma Pass Solid compositions containing polyethylene oxide and an active ingredient
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
CN1088584C (zh) * 1996-08-02 2002-08-07 久光制药株式会社 口服制剂用胶囊及口服胶囊制剂
JPH10152431A (ja) * 1996-08-02 1998-06-09 Hisamitsu Pharmaceut Co Inc 経口製剤用カプセルと経口カプセル製剤
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
KR100522248B1 (ko) * 1997-05-29 2006-02-01 동아제약주식회사 이중제어방출막구조의경구서방성제제및그제조방법
DE19726282A1 (de) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
JPH11246439A (ja) * 1998-03-02 1999-09-14 Hisamitsu Pharmaceut Co Inc 経粘膜用吸収促進剤
EP0972563A1 (en) * 1998-07-15 2000-01-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
WO1999047253A1 (en) * 1998-03-19 1999-09-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
ATE433747T1 (de) * 1998-03-19 2009-07-15 Max Planck Gesellschaft Verfahren zum aufbringen mehrerer schichten von beschichtungssubstanzen auf templatpartikel
JPH11335269A (ja) * 1998-05-19 1999-12-07 Hisamitsu Pharmaceut Co Inc 遺伝子関連医薬の経口投与固形製剤
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
FR2781666B1 (fr) * 1998-07-30 2000-09-08 Oreal Composition cosmetique solide et ses utilisations
KR100336975B1 (ko) * 1998-08-11 2002-08-22 한국화학연구원 약물방출제어용패취
DE69925007T2 (de) * 1998-09-21 2006-02-02 Amato Pharmaceutical Products, Ltd., Fukuchiyama System zur oralen wirkstoffabgabe zur steigerung der bioverfügbarkeit von aktiviertem glycyrrhizin
JP4599714B2 (ja) * 1999-01-22 2010-12-15 アステラス製薬株式会社 経口吸収改善医薬用組成物
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
DE60038097T2 (de) * 1999-02-22 2009-02-12 Merrion Research I Ltd. Feste orale dosierungsform enthaltend einen resorptionsverstärker
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
AU1186401A (en) 1999-06-23 2001-01-22 Sedum Laboratories, Inc. Ionically formulated biomolecule microcarriers
WO2001002014A1 (fr) 1999-07-02 2001-01-11 Hisamitsu Pharmaceutical Co., Inc. Compositions medicamenteuses destinees au traitement du cancer colorectal
DE19943420A1 (de) * 1999-09-08 2001-03-15 Beiersdorf Ag Mascara und Augenbrauenstifte mit einem Gehalt an fluormodifizierten Kammpolymeren
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
ATE361061T1 (de) 2000-04-20 2007-05-15 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
KR100411195B1 (ko) * 2000-09-26 2003-12-18 한국화학연구원 케토롤락 트로메타민이 함유된 서방형 펠렛
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US7700572B2 (en) * 2001-11-02 2010-04-20 Giuliani International, Ltd. SMAD7 inhibitors for the treatment of CNS diseases
JP2003201256A (ja) * 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
US7007417B2 (en) * 2002-01-18 2006-03-07 M.H. Segan Limited Partnership Audio-visual display device for pictorial artwork
TWI355276B (en) * 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
FR2850577B1 (fr) * 2003-02-03 2005-04-15 Ethypharm Sa Particules enrobees a gout masque, leur procede de preparation et comprimes orodispersibles contenant lesdites particules
US20060188563A1 (en) * 2003-03-27 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
ITRM20030149A1 (it) 2003-04-02 2004-10-03 Giuliani Spa Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
US7550557B2 (en) 2003-08-29 2009-06-23 Louisiana Tech University Foundation, Inc. Multilayer films, coatings, and microcapsules comprising polypeptides
US7544770B2 (en) 2003-08-29 2009-06-09 Louisiana Tech Foundation, Inc. Multilayer films, coatings, and microcapsules comprising polypeptides
US7348399B2 (en) 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
JP4521554B2 (ja) * 2004-03-31 2010-08-11 マイラン製薬株式会社 シクロスポリン製剤
DE102004035936A1 (de) * 2004-07-23 2006-03-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
CN100486568C (zh) * 2004-08-26 2009-05-13 复旦大学 洛索洛芬钠缓释制剂
WO2007117706A2 (en) 2006-04-07 2007-10-18 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
CN101259140B (zh) * 2007-03-08 2012-08-22 重庆北碚现代应用药物研究所 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
WO2008117814A1 (ja) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. 大腸送達用経口製剤
WO2009048073A1 (ja) * 2007-10-09 2009-04-16 Takeda Pharmaceutical Company Limited 顆粒の被覆方法
DE102008003615A1 (de) 2008-01-09 2009-07-16 Magforce Nanotechnologies Ag Magnetische Transducer
US20090280169A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
EP2172193A1 (en) * 2008-10-02 2010-04-07 Capsulution Nanoscience AG Improved nanoparticulate compositions of poorly soluble compounds
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
BR112013017169A2 (pt) 2011-01-07 2016-10-04 Merrion Res Iii Ltd composições farmacêuticas de ferro para administração oral
AU2012292554B2 (en) 2011-08-10 2014-10-30 Magforce Ag Agglomerating magnetic alkoxysilane-coated nanoparticles
DK2659881T3 (en) * 2012-04-30 2018-02-05 Tillotts Pharma Ag Delayed release drug formulation
US9763887B2 (en) 2013-03-15 2017-09-19 Allergan Pharmaceuticals International Limited Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4627851A (en) * 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
JPH0813748B2 (ja) * 1990-04-23 1996-02-14 帝國製薬株式会社 大腸崩壊性ポリペプチド系経口製剤

Also Published As

Publication number Publication date
EP0667148A1 (en) 1995-08-16
EP0667148B1 (en) 2002-07-03
KR0157280B1 (ko) 1998-11-16
WO1994010983A1 (en) 1994-05-26
ES2176209T3 (es) 2002-12-01
CA2148465A1 (en) 1994-05-26
EP0667148A4 (en) 1997-02-26
CA2148465C (en) 1999-11-02
AU5376894A (en) 1994-06-08
US5654004A (en) 1997-08-05
DE69332082T2 (de) 2003-02-06
DE69332082D1 (de) 2002-08-08
DK0667148T3 (da) 2002-07-22

Similar Documents

Publication Publication Date Title
KR950703938A (ko) 하부소화관 방출성의 경구의약제제(oral pharmaceutlcal preparation releasable in the lower digestive tract)
KR100196256B1 (ko) 서방성 약물 제형
FI118626B (fi) Kooloniin annettava lääkekoostumus
Klausner et al. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans
FI85216C (fi) Foerfarande foer farmstaellning av ett oralt administrerbart farmaceutisk preparat av 5-amino-salicylsyra.
US6063400A (en) Targeted liposomal constructs for diagnostic and therapeutic uses
EP0827398B1 (en) Pharmaceutical dosage form for colonic delivery
AU2007206582B2 (en) Microspheres comprising nanocapsules containing a lipophilic drug
US6458383B2 (en) Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
KR100360636B1 (ko) 액체제제내의약물투여용제형
US20030166508A1 (en) Biologically active oral preparation that can be site-specific released in colon
JP2003506476A (ja) 親水性治療剤の増強された吸収のための組成物および方法
EP0825854A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
JP2007532689A (ja) 医薬有効成分の遅延性かつ調節性放出のための微粒子経口ガレヌス製剤
AU2005226927A1 (en) Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (LK-423)
KR100531065B1 (ko) 활성제 방출이 제어된 의약 제제
WO1996036338A1 (en) Bisacodyl dosage form for colonic delivery
JPH11502842A (ja) 結腸投与のためのアザチオプリン組成物
JPH10203964A (ja) 難吸収性薬剤の経口生物学的利用能を改善する新しい調剤
CA2290969C (en) Delayed-release dosage forms of sertraline
KR20000053326A (ko) 결장내 운반에 사용되는 다층 장용성 중합체 코팅물을 갖는 약제학적 제형
CZ118899A3 (cs) Kompozice s pozvolným uvolňováním léčiva, způsob přípravy této kompozice, způsob zlepšení profilu uvolňování léčiva a použití této kompozice
Meade III Drug therapy reviews: clinical pharmacology and therapeutic use of antimycotic drugs
WO2017134524A2 (en) Spherical microcapsules with enhanced oral bioavailability
Shah et al. DEVELOPMENTS IN COLON SPECIFIC DRUG DELIVERY SYSTEMS-A REVIEW.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030512

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee